
NARI
Healthcare · Medical Devices · $4.68B market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2024
EPS trend, 90 days to now · -38.2% over 90 days · 30-day revisions 8 up, 2 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 28, 2024 | After the close | -0.13 | -0.09 | +30.8% |
| Jul 30, 2024 | After the close | -0.15 | -0.38 | -153.3% |
| Apr 30, 2024 | After the close | -0.20 | -0.22 | -10.0% |
| Feb 28, 2024 | After the close | 0.01 | -0.08 | -900.0% |
| Nov 1, 2023 | After the close | -0.01 | 0.05 | +600.0% |
| Aug 2, 2023 | After the close | -0.13 | 0.04 | +130.8% |
| May 3, 2023 | After the close | -0.23 | -0.04 | +82.6% |
| Feb 27, 2023 | After the close | -0.17 | -0.11 | +35.3% |
| Nov 2, 2022 | After the close | -0.25 | -0.19 | +24.0% |
| Aug 3, 2022 | After the close | -0.23 | -0.19 | +17.4% |
| May 4, 2022 | After the close | -0.09 | -0.06 | +33.3% |
| Feb 23, 2022 | After the close | 0.03 | 0.02 | -33.3% |
| Nov 9, 2021 | After the close | -0.11 | -0.06 |
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration…
| +45.5% |
| Aug 10, 2021 | After the close | 0.08 | 0.07 | -12.5% |
| May 11, 2021 | After the close | 0.05 | 0.13 | +160.0% |
| Mar 9, 2021 | After the close | 0.01 | 0.13 | +1200.0% |
| Nov 12, 2020 | After the close | -0.04 | 0.12 | +400.0% |
| Aug 11, 2020 | After the close | -0.18 | -0.16 | +11.1% |
| May 26, 2020 | After the close | 0.09 | -0.02 | -122.2% |
| Feb 21, 2020 | Time not confirmed | — | -0.02 | — |